Qureator, Inc.
Qureator, Inc.
Qureator, Inc.
Home
Technologies
Disease Models
Cancer Metastasis
Cancer vTIME for Immunotherapy
Age-related Macular Degeneration (AMD)
Drug Induced Liver Injury (DILI)
Blood Brain Barrier (BBB)
Curiochips
AI
Therapeutic Applications
News
About
Contact
Home
Technologies
Disease Models
Cancer Metastasis
Cancer vTIME for Immunotherapy
Age-related Macular Degeneration (AMD)
Drug Induced Liver Injury (DILI)
Blood Brain Barrier (BBB)
Curiochips
AI
Therapeutic Applications
News
About
Contact
News & Publications
Qureator’s Historic FDA IND Approval Based on Human-Relevant Data Highlighted in The BIO
November 25, 2025
|
Tags :
Press highlights
,
Qureator Achieves World’s First FDA IND Approval Using Only Human Vascularized Organoid Efficacy Data
October 27, 2025
|
Tags :
Press highlights
,
Spotlight
,
Qureator’s Collaboration Highlighted in Korean Economic Daily
March 18, 2025
|
Tags :
Press highlights
,
News
Publications
Public Biddings
All
Activities
Press highlights
Spotlight
Select Category
All
Activities
Press highlights
Spotlight
주식회사 큐리오칩스 유세포분석기 공개입찰 공고문 안내
June 5, 2026
|
Tags :
up